CFO Suketu Upadhyay said the company now expects a charge in 2025 of about $40 million, compared with a range of $60 million ...

Chips are one of several product types currently under Section 232 investigation by the White House, a frequent precursor to duties.

Edwards Lifesciences and JenaValve said they remain committed to completing the deal and would defend the case in court.

The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to ...